On August 5, Clorox rose 5.01% in regular trading, trading at $103.19/share, with turnover of $272 million. The rally was driven by better-than-expected fiscal Q4 results and subsequent price target upgrades from multiple investment banks.

Clorox reported fiscal Q4 adjusted EPS of $1.66, beating the consensus estimate of $1.65, while revenue of $1.948 billion exceeded the $1.898 billion estimate. The company issued fiscal 2027 adjusted EPS guidance of $5.70 to $6.00, bracketing the analyst consensus of $5.93. Following the results, Wells Fargo raised its price target from $95 to $102 while maintaining an Equalweight rating.

However, challenges remain. RBC Capital Markets cut its fiscal 2027 adjusted earnings estimate to $5.85 from $6.12 after Clorox issued weaker-than-expected gross margin guidance, citing weak demand, cost pressure, and continued headwinds in charcoal and litter segments. The company itself acknowledged that the operating environment heading into fiscal 2027 will remain difficult amid cost volatility and increasingly value-conscious consumers.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)